Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.
Germany is inching toward legalizing recreational cannabis as the government seeks to have the process completed by the end of 2022. The latest push is coming from the country’s Health Ministry which undertook expert hearings on various aspects of the issue with a focus on the best ways to protect young people and consumers’ health.
The move could be a major catalyst for the market, especially for cannabis companies such as Tilray Brands, Inc. (NASDAQ:TLRY), which has operations in Germany.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!
Cantor Fitzgerald’s analyst Pablo Zuanic said in his recent note that the sentiment for the company's stock may improve going forward.
“We expect sentiment for the stock to improve in the months ahead on the back of news flow from Germany on the legalization of recreational sales,” Zuanic said.
The Analyst
Zuanic retained a Neutral rating on the company’s stock with a price target of $5.75, down from $6.15.
The Thesis
The company is poised to benefit from being one of only three cannabis licensed manufacturers in Germany.
FREE REPORT: How To Learn Options Trading Fast
In this special report, you will learn the four best strategies for trading options, how to stay safe as a complete beginner, a 411% trade case study, PLUS how to access two new potential winning options trades starting today.Claim Your Free Report Here.
The Canadian cannabis giant finalized its first harvest of medical cannabis grown in Germany via its subsidiary Aphria RX GmbH in July 2021, several months following the merger with Aphria.
The company is scheduled to report the fiscal fourth quarter at the end of July. Zuanic tweaked his sales estimates, lowering EBITDA assumptions and saying that Tilray has “become somewhat of a meme stock, in our opinion, with significant volatility to the heavy presence of retail investors.”
Strategic Partnership With HEXO
In the meantime, it remains to be seen how the agreement with HEXO Corp. (NASDAQ:HEXO) will play out.
Earlier this year, the Canadian cannabis giant entered into a strategic partnership with HEXO - a debt financing agreement - under which it agreed to acquire $211 million in senior secured convertible notes that HEXO originally issued to HT Investments MA LLC. In April, Tilray signed a definitive agreement to purchase 100% of the remaining US$193 million outstanding principal balance of the senior secured convertible note.
Last week, that deal was amended to address current stock market conditions and to reduce closing risk.
Zuanic said recently that Tilray could benefit from “HEXO’s travails,” leveraging the current state of the markets and the crisis HEXO is facing to negotiate terms, spend less cash and eventually convert the debt in a 50% equity stake in the company.
TLRY Price Action
Tilray's shares traded 0.2123% higher at $3.5876 per share at the time of writing on Firday.
Benzinga photo. Source: Image from Shutterstock
Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.